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Abstract
  The paper reviews and evaluates current and future approaches to cost containment in the United
States. Managed care was once seen as an effective approach to supporting health care quality while
containing         costs in the USA. In recent years payors started to look in other directions, since
prospects for limiting expenses faded. Nowadays consumer driven health plans seem to be on the
rise. The reasons for the decline of managed care, the growing popularity of the consumer driven
health plans and the implications for Europe are discussed. 
Introduction
On an international basis, the development of health care
policy is increasingly being influenced by cost considera-
tions. Advances in health science and the delivery of care
continue to expand the capabilities of treatments. The
ability of nations and communities to pay for this care
from available resources is a major subject of debate.
One focus of this debate has been research comparing
health care utilization in Europe and the United States.
Research has frequently demonstrated that, while Europe
has greater capacity and higher utilization of services than
the United States, Americans are paying more for these
services. This discussion has intensified as nations on
both sides of the Atlantic struggle to provide health and
other programs while maintaining economic stability
[1,2].
Frustrating as they may be for health care providers and
payors, this situation presents important opportunities
for research concerning health care policy. In particular,
the experience of the United States during recent years,
contains significant economic challenges with direct
implications for health care financing and delivery. After
eliminating federal budget deficits during the 1990s,
America has generated a new round of shortfalls (exceed-
ing $400 billion) annually through a combination of
international military involvements and an economic
downturn. This situation may impact Medicare, the major
source of health care funding for the elderly and the larg-
est single payor for these services [3,4].
Resource limitations are also challenging other major
health care payors in the United States. Private insurance
has carried the burden of cost shifting from public payors
and has also suffered from the impact of the economic
recession [4]. The Medicaid program, which funds health
services for the indigent and elderly, has been challenged
by budget difficulties of many state governments [5,6].
The pressures that are being exerted by these develop-
ments on the health care system of the United States
promise to create opportunities for policy making con-
cerning cost containment during the immediate future.
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The Bush Administration is already rediscovering Medi-
care managed care [7]. This type of activity could spill over
to into other areas of the economy as the administration
struggles to reconcile the costs of international commit-
ments and domestic programs with its recent tax
reductions.
Beyond these circumstances, current and future
approaches to cost containment in the United States need
to be viewed in a broader context. Managed care for a vari-
ety of payors was once seen as an effective approach to
supporting health care quality while containing costs.
During the past decade, the attractiveness of this approach
to many employers has faded and prospects for limiting
health care expenses have become confused [8]. These
developments caused payors in America to look in other
directions for approaches to containing health care
expenses.
In this context, the recent experience of the United States
with respect to health care and its economic impact may
have valuable implications for that nation and for the rest
of the world. In order to understand these implications,
the development of managed care and other approaches
to health care policy must be reviewed and evaluated. To
provide a broad view of these changes, this information is
presented as a review of existing sources and data rather
than the development of completely new information.
Development of Managed Care in the United 
States
Historically, managed care evolved in the United States to
influence the use of medical care by improving outcomes
and efficiency. The past three decades of experience with
this approach suggests that at least some of these objec-
tives have been realized.
During the second half of the twentieth century, managed
care developed in the United States as a mechanism for
constraining the growth of health care costs by controlling
the delivery system. This approach originated in the west-
ern United States in the form of staff model plans such as
Kaiser Permanente which employed physicians and other
caregivers directly. In the private health insurance indus-
try, managed care plans controlled costs and the delivery
of care by restricting hospital utilization, such as admis-
sions and lengths of stay, by limiting access to specialists,
and by encouraging healthful behaviors among subscrib-
ers [9].
The popularity of managed care in the private sector of the
American economy encouraged its adoption by public
payors. The size of the Medicare program and the growth
of health care expenses for the elderly stimulated the fed-
eral government to offer Medicare managed care options
during the 1970s and 80s [10]. State governments, bur-
dened with health care expenses for the indigent and eld-
erly, and lacking the ability to run operating deficits,
became even more interested in this approach [11].
During the 1980s and 90s, managed care expanded rap-
idly in the United States. In private health insurance, a
major shift occurred from traditional indemnity insur-
ance to managed care plans in many markets. This devel-
opment was stimulated by an increase in the numbers of
businesses offering managed care as an option to employ-
ees. The proportion of employees in large firms (those
with more than 200 employees) enrolled in managed care
plans grew from 5 percent in 1984 to 50 percent in 1993
[12]. As the use of managed care spread, interest in tradi-
tional indemnity plans declined. By 1998, only 14 percent
of employees in large firms were enrolled in indemnity
insurance plans [13].
During the 1980s and 90s, increased enrollment in private
sector managed care in the United States was spurred by
the ability of this approach to contain health care costs.
The data in Table 1 demonstrate that, by 1997, average
monthly insurance premiums for these plans were lower
than for private health insurance. The data also indicate
that the differences between premiums were greatest in
areas where managed care penetration was lowest ($52
lower than non managed care plans) and in areas where
managed care penetration was highest ($35 lower). This
information suggests that managed care was successful in
controlling costs in a variety of settings.
Table 1: Average monthly insurance premiums by type of insurance plan, 1997.
Average Family Premiums ($)
All Plans Managed Care Non Managed Care
HMO Penetration
Less than 25 Percent 439 401 453
25 – 35 Percent 417 408 423
35 – 45 Percent 400 400 401
45 Percent or More 394 380 415
Source: 1997 Robert Wood Johnson Foundation Employer Health Insurance Survey.Health Research Policy and Systems 2005, 3:4 http://www.health-policy-systems.com/content/3/1/4
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The expansion of managed care in the private sector of the
United States was paralleled by increased adoption of this
approach by public payors. Historically, the level of finan-
cial risk generated by the elderly and indigent, the major
populations covered by Medicare and Medicaid, had lim-
ited government interest in privatizing these plans and the
participation level of insurance companies in this area.
The failure of the Clinton administration to enact
national health care reform did not impede the develop-
ment of Medicare managed care. This approach expanded
rapidly during the 1990's, fueled in part by the introduc-
tion of flexible plans. Enrollment in Medicare managed
care, which had remained close to 1,000,000 between
1985 and 1991, increased to more than 6,000,000 by
1999 [14].
In the same period, State governments turned to managed
care as a means of constraining health care costs. With
fewer resources than the federal government, States had
more incentives to use this approach. Between 1997 and
2001, enrollment in full risk Medicaid managed care
plans increased by 40.6 percent [15].
The development of managed care in the United States
was stimulated by interest in improving both outcomes
and efficiency of health care. During the 1980s and 90s,
the proliferation of this approach was related to pressure
for efficiency and cost containment. In this role, managed
care performed well throughout most of the two decades.
As the use of this approach by all payors increased, the
annual per cent change in per capita health spending in
the nation declined from 5.0 – 6.9 between 1991 and
1993 to 2.0 – 2.2 between 1994 and 1996. Among private
health insurance plans, where managed care penetration
was highest, annual per capita changes in premiums
declined from 12.5 percent in 1988 to 4.8 percent in 1997
[16].
Available evidence indicates that managed care was able
to reduce health care expenses in the United States
through constraints on utilization of service. From its
beginnings, traditional managed care controlled utiliza-
tion of hospital care, a major source of health care costs,
through physician gate keeping and pre authorization
mechanisms. In the western part of the nation, where use
of this approach was highest, it supported hospital admis-
sion rates and length of stay that were lower than those in
other areas. During 2002, the hospital admission rate for
the western region of the United States (955.4 per 10,000
population), was 18.6 percent below the national average
(1,174.6 per 10,000). During the same period, the mean
hospital stay in the west (4.4 days) was 8.9 percent below
the national average (4.9 days) [17].
Reductions in health care utilization brought about by
managed care in the western United States have been
adopted in other areas of the nation and the world. Physi-
cian profiling and the development of preferred provider
arrangements with long term care providers have been
employed by providers and payors to constrain hospital
utilization and related to costs [18].
The Decline of Managed Care
In retrospect, it appears that the success of managed care
in the United States during the last decades of the twenti-
eth century also led to its undoing. Health care is a
dynamic sector of many national economies. Upon
review of the American experience, it seems that a number
of factors contributed to the decline of this approach.
The initial wave of opposition to managed care appeared
as challenges to control of health care utilization, such as
choice of providers. Physicians were never reconciled to
allowing insurance plans to choose practitioners and hos-
pitals. During the 1990's, a wave of class action litigation
was directed at the ability of plans to direct referrals for
health services. The plaintiffs in these cases, including
consumers, physicians, and other providers, sought finan-
cial damages and injunctions against managed care busi-
ness practices. Although courts in the United States were
reluctant to declare the costs control methods of plans
illegal, the full range of litigation supported negative per-
ceptions of managed care among consumers and busi-
nesses [19].
During the late 1990s, the legal reaction against managed
care in the United States was accompanied by deteriorat-
ing relationships between plans and health care providers.
Increased consumer dissatisfaction with the business
practices of plans, including apparent arbitrary denials of
service and failure to pay claims promptly, added fuel to
provider complaints about low payment rates. Providers
also objected to the terms of risk contracting agreements
which required them to carry a significant burden of phar-
maceutical costs and other expenses. All of these develop-
ments generated a wave of opposition to managed care by
hospitals and physician groups. These activities frequently
resulted in the termination of contracts and network
instability [20,21].
During the second half of the 1990's, consumer litigation
and provider reactions against managed care caused these
many of these plans to change their traditional business
approaches. In order to regain the favor of consumers and
providers, plans in many communities loosened controls
on provider utilization. Plans relaxed the use of physi-
cians as gate keepers and allowed consumers direct access
to specialists. Requirements for referrals to other types of
services were loosened. Stringent authorizationHealth Research Policy and Systems 2005, 3:4 http://www.health-policy-systems.com/content/3/1/4
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procedures for use of hospital emergency departments
and for certain surgical procedures were also relaxed. This
process amounted to a substantial movement away from
the aggressive health care management approaches which
had supported the rise of this approach [22].
To replace these utilization control mechanisms, many
managed care plans introduced mechanisms that
included more interaction with subscribers, such as case
management and electronic information exchange. Sub-
scribers were encouraged to modify health related behav-
iors by visiting web sites and obtaining additional
information concerning preventive care. In many commu-
nities, managed care plans placed increased emphasis on
wellness programs and disease management. The industry
was shifting its focus from controlling utilization to influ-
encing it.
The retreat from direct management of health care utiliza-
tion toward softer approaches led to a general weakening
of accountability to consumers. With fewer direct controls
in place and greater reliance on indirect mechanisms the
assessment of performance of individual plans by busi-
nesses and government became more difficult [8].
Related to these approaches, some managed care plans
adopted business strategies which placed greater empha-
sis on profitability. Chief among these was a movement
away from contracting for high risk populations. Facing
increased dissatisfaction from consumers and greater
competition from traditional insurance in the market
place, private plans in many areas increasingly focused on
lower risk populations as a means of improving profita-
bility. As a result, many private managed care plans with-
drew from participation in public managed care programs
with high risk populations such as the elderly (Medicare)
and the indigent (Medicaid). Between 1998 and 2000, the
number of plans serving Medicare patients declined by 20
percent. By 2002, total Medicare managed care enroll-
ment was lower than it had been in 1997. Between 1998
and 2000, the number of insurance plans participating in
Medicaid declined by 15 percent. The development had a
major impact on State governments because more than
half of all Medicaid recipients were enrolled in managed
care [23].
Increased efforts by managed care plans to compete in the
United States health care marketplace also led to the
adoption of other business strategies characteristic of tra-
ditional insurance. These included reduced a greater
emphasis of raising premiums to support profitability.
This approach effectively passed along a higher propor-
tion of health care expenses to subscribers. Managed care
plans also catered more to consumer preferences in order
to expand market share [24].
All of these activities effectively changed managed care
from its traditional structure in the United States. As the
focus on continuity of care and regulation of utilization
diminished, managed care plans became more like other
types of insurance such as indemnity plans and preferred
provider organizations. As choice of providers was substi-
tuted for gate keeping, physicians and increased premi-
ums took the place of utilization controls, the line
between managed non managed care became blurred.
This entire process amounted to a decline of managed care
shortly after the approach had reached its highest level of
acceptance. This decline was reflected in a decreased abil-
ity of managed care to restrain costs, a major reason for
the increased use of this form by payor during the 1980s
and 90s. As a result of this development, a major barrier
to health care spending was removed and per capita
expenditures began to rise. This situation is illustrated by
changes in annual per capita health care spending for all
payors in the United States, summarized in Figure 1.
This information identifies both the zenith and the
decline of managed care. Between 1994 and 1996, the
impact of this approach reached a high point, as annual
increases in per capita spending declined to only about
two percent per year. The decline of managed care during
the late 1990s produced a rapid erosion of this position.
Annual increases in per capita spending nearly quadru-
pled to almost eight percent by 2000 and kept increasing
after the turn of the century.
These developments were paralleled by in annual
increases of changes in per capita spending for private
health insurance, the area of the economy in which man-
aged care developed prior to the 1970s. After declining to
less than five percent in 1997, annual increases in per cap-
ita expenses for private health insurance rapidly recovered
to over 10 percent after the turn of the century. These
developments are summarized in Figure 2.
The increases in pre capita health expenditures identified
in these tables occurred because of a retreat from tradi-
tional cost controls by managed care plans and because of
the transfer of many expenses to consumers. As previously
noted, changes in the behavior of these plans in some
metropolitan areas included less reluctance to raise premi-
ums, rather than contain costs, in order to avoid operating
losses. Many of the 'soft' programs that were added in
order to compete with traditional health insurance were
offered at an additional cost.
This information concerning the impact of managed care
on health care expenses does not identify the impact of
the decline of the approach on continuity of care and
other outcomes, for which quantitative data are notHealth Research Policy and Systems 2005, 3:4 http://www.health-policy-systems.com/content/3/1/4
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available. It might be assumed that, with increased
emphasis on consumer choice and less attention to con-
trol of referrals and provider participation, the integrity of
care across health systems also deteriorated during this
period.
All of these developments effectively moved managed care
plans in the United States closer to traditional insurance
plans in their behavior and impact on health care expen-
ditures. They undermined the ability of this approach to
differentiate itself from traditional health insurance as a
mechanism which actively managed care and contained
costs. They made it considerably more difficult for the
approach to exert a direct impact on health care outcomes.
Ironically, these characteristics had been the major selling
points of the approach since its inception.
It should be noted that, during this period, traditional
insurance plans have also moved toward managed care by
adopting features of health maintenance organizations
such as utilization controls. As a result, the border
between these two types of insurance is now almost non
existent.
The change in the character of managed care also had pro-
found implications for the future of health care cost con-
tainment in the United States. It deprived government
and the private sector of one of their most powerful
Annual percent change per capita health care spending United States 1991 – 2002 Figure 1
Annual percent change per capita health care spending United States 1991 – 2002.
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weapons in restraining expenditures. It also signaled an
important change in the direction off public and private
sector health policy. The movement of managed care away
from utilization controls and toward higher premiums
shifted the burden of health policy toward the consumer.
It suggested that payors would support consumers in
shaping health care and the organizations that provide it,
rather than having the payors assume leadership. This
change would lead to important developments in the pol-
icy environment of this sector.
The Rise of Consumer Driven Health Care
The decline of managed care as the major driver of health
care policy and reimbursement within the United States
has opened the way for new forces to shape this area. The
nature of these forces became visible in the late 1990s as
managed care plans shifted responsibility for health care
decision making to consumers. The resulting annual
increases in health care expenditures, summarized in Fig-
ure 1 and 2, were also effectively shifted to consumers
through higher premiums, deductibles, and copayments.
For example, in preferred provider organizations, the
most widely used health plans, single coverage deducti-
bles increased more than 50 percent between 2002 and
2003. More employers began offering high deductible
plans. The rate of increase of out of pocket spending has
increased every year between 2000 and 2003 [25,26].
The rise of increased consumer involvement in health care
in the United States has developed on several fronts. At
Annual percent change per capita spending for private health insurance United States 1988 – 2002 Figure 2
Annual percent change per capita spending for private health insurance United States 1988 – 2002.
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the broadest level, it has taken the form of a greater con-
sumer role in decision making concerning treatment. In
the late 1990's the use of television, newspapers, and elec-
tronic media to market health care to consumers became
pervasive. Drug companies became major users of this
approach. They have conducted enormous media cam-
paigns to promote the use of sexual stimulants, allergy
medicines, and cosmetic treatments. Access to large mar-
keting budgets has made it possible for these companies
to reach millions of consumers with their messages. Local
and regional diagnostic firms have also marketed mag-
netic resonance imaging and whole body scanning
through similar campaigns [27].
These efforts have been successful because they gone
directly to users of health care. They have circumvented
insurance companies, managed care, and even physicians.
Listeners are urged to 'ask' or 'tell' their doctor to prescribe
any number of medications or tests. The clear message of
all of these initiatives is for individual consumers to take
a greater role in health care decision making. Greater user
involvement in health care that was stimulated by the
decline of managed care, as well as media initiatives of the
pharmaceutical industry and other groups, have led
directly to the development of a new type of health insur-
ance in the United States, the consumer driven health
plan. These mechanisms complete the change initiated by
the decline of managed care by directly assigning health
care decision-making to consumers.
Consumer driven health plans are designed to address the
major objectives of managed care, development of health-
ful behaviors and containment of health care costs. Com-
ponents of consumer driven plans usually include the
following.
- High deductibles as incentives for greater consumer par-
ticipation in the cost of care
- Catastrophic coverage for high cost services such as inpa-
tient hospitalization
- Consumer savings accounts for funding of prevention
and screening services
- Procedures for roll over of unused savings account bal-
ances to future time periods
- Support for consumer decision making through availa-
bility of internet based information concerning health
care risk factors and provider outcomes
- Tracking of employee health expenses through the sys-
tem [28,29].
These components have been designed to replace struc-
tures of managed care plans which addressed the same
objectives. Encouragement of healthful behaviors and
health status objectives are addressed through consumer
savings accounts, rollover provisions, and internet based
information. These provisions have effectively transferred
responsibility for the management of care from the pri-
mary care physician gatekeepers employed by managed
care plans to the consumer. This transfer has been sup-
ported by a combination of financial incentives and elec-
tronic data [28,30].
Consumer driven health plans also contain provisions for
cost containment. High deductibles and catastrophic
coverage are intended to limit expenditures by payors.
These provisions effectively reduce expenses for many of
the pharmaceutical and ambulatory care expenses cur-
rently being pushed by media advertising. By excluding
payor reimbursement for them, these plans are transfer-
ring these expenses to the consumers, or providing incen-
tives to eliminate the purchases altogether. This amounts
to a cost containment approach very different from the
utilization controls employed by managed care plans
[31].
The implementation of consumer driven health plans has
generated extensive controversy in the American health
care system. Supporters of this approach have argued that
it is logical because it places major responsibility for
health care decision making in the hands of the party who
will be most influenced by those decisions, the consumer.
They have emphasized that, under these plans, positive
health care behaviors and decision making are rewarded
by fewer out of pocket expenses. They have also noted that
consumers are provided with extensive electronic infor-
mation needed to support effective decision-making
[30,32].
Supporters of consumer driven plans also have suggested
that these approaches include realistic mechanisms for
health care cost containment. They have pointed out that
managed care relied on limitations on the utilization of
care to limit spending, while consumer driven plans
assign these decisions to users of care. They have suggested
that the new approach can satisfy both the payor and the
consumer, by limiting insurance expenses for care and
allowing individuals to purchase additional services [28].
Opponents of consumer driven health care have argued
that this approach is inferior to managed care, that it is a
mechanism for employers and payors to abdicate their
responsibilities. They have suggested that, rather than sup-
porting consumers with the advice of physicians and
other health care providers, it turns them loose to make
decisions on their own. They have indicated that a set ofHealth Research Policy and Systems 2005, 3:4 http://www.health-policy-systems.com/content/3/1/4
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financial incentives and internet based information is no
substitute for the relationship between a patient and a car-
egiver [29].
Opponents of consumer driven plans also argued that the
real purpose of these approaches is financial, that they are
better identified as defined contribution plans. Oppo-
nents of these plans suggested that they are really covers
for the abdication of financial responsibility by payors.
They have argued that the major purpose of these plans is
to shift health care costs from employers to employees.
They have contended that high deductibles and cata-
strophic coverage are the real solution for employers and
payors seeking to reduce premiums, regardless of the
impact on subscribers [30,31].
The debate concerning consumer driven health care is
probably only beginning in the United States. It bears sim-
ilarities to the discussion surrounding the rise of managed
care in the 1970s and 80s. One important difference
between these situations may be the economic back-
ground. The ascendancy of managed care developed
against the background of an upturn. Consumer driven
care is developing at a time of economic instability and
limited resources. Indeed, these conditions may be sup-
porting the rise of the new approach.
A review of the current status on consumer driven plans
suggests that they are still evolving. Many of these plans
are still developing their own provider networks. Others
are partnering with existing plans in order to expedite the
process. Some plans are developing generic fee schedules
for services and allowing consumers to develop their own
networks. Consistent with this approach, consumers
cover additional health care costs from their own
resources [31].
The development of information infrastructure has
become an important part of the implementation of con-
sumer driven plans. In order to involve consumers in a
meaningful way, plans must make available extensive
electronic data to support decision making. These data
include a variety of online sources of information includ-
ing many types of research. They also must include finan-
cial information concerning provider prices and
discounts. In order to enable consumers to participate in
health care decision making on a continuing basis, plans
must also make available data concerning consumer
accounts which identify the impact of choices on available
funds. The plans which are entering the consumer driven
market in a serious manner must have all of these infor-
mation resources available. They require an extensive
investment in data infrastructure [31].
The implementation of consumer driven health plans is
proceeding rapidly in the United States. Because of the
size of the American population, it still occupies a rela-
tively small proportion of the health care market. The data
in Figure 3 demonstrate that, by 2004 enrollment in con-
sumer driven health plans is projected to reach 1,000,000.
This enrollment is still dwarfed by existing traditional
insurance and managed care populations.
The distribution of consumer driven health care enroll-
ment across employers is summarized in Figure 4. This
data indicate that market penetration by these plans is still
modest, but that it has established a foothold in a wide
range of employers [28]. This suggests that interest in
these plans is not limited by employer size.
It should be noted that these data reflect the growth of
consumer driven plans among private insurance plans.
This approach has not yet been tested with Medicare or
Medicaid populations. These effort may require the devel-
opment of new designs for plan components, especially
those which involve consumer decision making, because
of differences in health care mind sets and behaviors
among the elderly and the indigent.
The future of consumer driven health care in the United
States is difficult to predict. Additional time and utiliza-
tion data will be required to determine whether this
approach generates sufficient enrollment to develop into
a major force within the health care system of the United
States and whether other nations adopt it.
Implications for Europe
The recent development of managed care and consumer
driven health care in the United States has important
implications. Rightly or wrongly, the American health
care system has historically been a source of approaches
for implementation in Europe and elsewhere. The
amount of change and innovation that has marked this
system in recent years has generated more than enough
material for consideration by the international
community.
One of the most significant developments in the United
States health care system in the past several years has been
the decline of managed care. This development probably
came as a surprise to health care policy makers elsewhere
in the world. In its early days, managed care had great
promise for addressing the two most important objectives
of health care planning, improving patient outcomes
while containing costs. During the 1980s, this approach
seemed to be on its way toward meeting this objective in
the American health care system. Managed care penetra-
tion of the private insurance, Medicare, and Medicaid
markets were increasing substantially and previousHealth Research Policy and Systems 2005, 3:4 http://www.health-policy-systems.com/content/3/1/4
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annual increases in per capita health care expenditures
were declining.
The reasons for the decline of managed care probably
emanate from conflicting forces within the American
health care system and the environment surrounding it.
These include the desire to support buyer preferences and
the need to restrain increases in health care expenditures
at the same time. In the American system during the late
1990s, cost containment lost out. The lesson that may
emerge from this is one of realism. You cannot have your
cake and eat it too.
At the same time, this story is more complicated than a
struggle between choice and cost containment. It is part of
a rising interest in consumer choice within the wider
health care environment and the economy of the United
States. Pharmaceutical companies and other providers of
health services have recognized this and begun direct mar-
keting to consumers through the media. This develop-
ment has involved bypassing physicians and going
directly to users of care, just as consumer driven care
involves bypassing managed care and its utilization con-
trols. These developments suggest that consumer driven
health care in the United States is not an isolated event,
but part of a wider trend.
These developments pose a major dilemma for health
policy makers. The parameters of this dilemma may differ
among nations. It can be suggested that, in the United
Participants in consumer drive health plans United States 2001 – 2004 Figure 3
Participants in consumer drive health plans United States 2001 – 2004.
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States, advocates of managed care should not have 'bailed
out' so quickly when consumer dissatisfaction began to
increase. This assumes that purchasers of care will ulti-
mately side with cost containment.
The preceding information demonstrates that the follow-
ing chain of events has occurred in the United States. Each
of these events was related to wider developments in the
American economy.
- Managed care helps reduce health care cost increases
- Increased managed care results generates popular
dissatisfaction
- Managed care plans reduce controls and increase prices
- Health care costs increase substantially
- Consumer driven plans provide a mechanism for gov-
ernment and employers to unload health care costs on
consumers
This important juncture is where Europe and the rest of
the world may have an advantage over the United States.
It is clear that Europe has the opportunity to invest in
managed care and to use this approach to restrain costs
and improve patient outcomes. In so doing, European
nations would stay with the first step on the preceding
Percent of employees adopting consumer driven health plans United States 2003 Figure 4
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chain of events and avoid the disadvantages of the
remaining ones.
But before we elaborate further on possible implications
for Europe, we should emphasize that the stage for the
health care actors in Europe is quite different from the one
in the USA. Health care systems in Europe vary greatly
among countries, but in general European health care sys-
tems have some characteristics that make them different
from the system(s) across the Atlantic. First, Europe has a
highly valued tradition of universal health care coverage
and governmental administration. Furthermore, Europe-
ans tend to entrust responsibility to the (central) govern-
ment and not to private agencies. Finally, competition
among providers and purchasers is restricted by highly
structured conditions by the government.
The above comes down to the point that in health care
Europeans have difficulties getting market elements off
the ground. They do not seem to trust the invisible hand
(of the market). This has probably resulted in a slower rate
of system innovation, but fewer policy development and
implementation errors, in these countries [33,34].
Germany, Switzerland and The Netherlands are nowadays
starting to adopt managed care (tools) with caution,
focusing on support for patient outcomes and cost con-
tainment. At the same time, Sweden and the United King-
dom, implemented dramatic changes very rapidly.
Obviously, Europe also offers the opportunity for a
number of different approaches to this issue to develop
simultaneously [35,36].
Any evaluation of the potential impact of consumer
driven health care in Europe must address specific aspects
of this approach. For example, what would be the impli-
cations of providing information concerning pharmaceu-
ticals directly to consumers in Europe? It could also be
conjectured that Europeans might prove to be more delib-
erate and conservative consumers of pharmaceuticals
than Americans. It could be suggested that Europeans
would make more extensive use of information before
reacting to the first television commercial and asking their
physicians for Viagra or Allegra, or some other drug. At the
same time, however, the answers to these questions are
not clear. They may vary substantially among European
countries [36,37].
A more important question regarding consumer driven
health care concerns the implications of exchanging free
choice of providers for higher cost sharing by consumers.
In societies with established medical networks which have
become acclimated to managed care, the free choice
option might have little impact. At the same time, the
recent strength of the European economies and the euro
might reduce the impact of higher cost sharing and make
free choice of providers more affordable [38,39].
Another area of consumer driven health care that deserves
evaluation is the potential impact of providing health
information directly to consumers on the use of services
and costs. In the United States, the effectiveness of this
approach depends greatly on the extent to which consum-
ers read, evaluate, and act on health information provided
through websites and other electronic media. It is clear
that Europeans probably make as much use of the internet
as Americans, however, it remains to be seen what the
impact of electronic medical information will be on con-
sumer behaviors in these countries [40].
The answers to these specific questions could vary sub-
stantially across the European continent. The degree to
which managed care is retained could be related to the
commitment of individual governments, the influence of
medical establishments, and the availability of disposable
income. From a policy making standpoint, this issue
probably requires evaluation on a nation by nation basis.
From an international standpoint, the potential impact of
the decline of managed care and the rise of consumer
driven health care in the United States is a fascinating
issue. It is still too early to determine what the impact of
these developments will be on the rest of the world. One
answer to this question is probably that changes in health
care policy require adequate information on the effective-
ness of the alternative being considered, as well as the sta-
tus quo. It appears that the difficulties with managed care
experienced by the United States during the 1990s have
prompted a rapid movement away from this form, with-
out a clear idea of the effectiveness of consumer driven
care, or other alternatives. Health care has too much of an
impact on large populations and on national spending to
approach it by 'looking before leaping'.
All of this suggests that Europe and the rest of the interna-
tional community are in an excellent position to profit
from the American experience without much risk. They
can view what is going on with critical eyes and reach their
own conclusions about whether the transition from man-
aged to consumer driven care supports patient outcomes
or not. They can monitor the data and determine which of
these forms has greater potential for cost containment.
The opportunities for learning may increase as financial
pressures place greater pressures on the American system
for cost containment.
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